Sort
50,496 grants matching “lung cancer”
SPORE: Developing New Rationale, Personalized Medicine for Lung Cancer
$750,052John D Minna · Ut Southwestern Medical Center · P50 · FY2016 · CA
Synthesis of Antitumor Natural Products
$750,028Samuel J Danishefsky · Sloan-Kettering Inst Can Research · R37 · FY2008 · CA
Molecular Therapeutics of Kidney Cancer: MET Gene and BHD Gene
$750,022William Marston Linehan · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
Vaccine and Drug Combination Therapy for Human Cancers
$750,008James Hodge · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA
Vaccine and radiation for the therapy of human cancers
$750,008James Hodge · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA
QUALITY RESEARCH IN RADIATION ONCOLOGY: ACR PCS
$750,000Jesse F Wilson · American College Of Radiology · R01 · FY2006 · CA
NRG ONCOLOGY NETWORK GROUP OPERATIONS CENTER
$750,000Norman Wolmark · Nrg Oncology Foundation, Inc. · U10 · FY2016 · CA
West Virginia Prevention Research Center
$750,000Geri A. Dino · West Virginia University · U48 · FY2019 · DP
PredicTOR: predicting patient response to mTOR pathway inhibitors prior to treatm
$750,000Michael Lebowitz · 20/20 Genesystems, Inc. · R44 · FY2010 · CA
Bruker timsTOF fleX MALDI-2
$750,000Michael P Snyder · Stanford University · S10 · FY2025 · OD
West Virginia Prevention Research Center
$750,000Geri A. Dino · West Virginia University · U48 · FY2022 · DP
West Virginia Prevention Research Center
$750,000Geri A. Dino · West Virginia University · U48 · FY2021 · DP
University of Colorado Cancer Center Support Grant - Lung Cancer Patient-Derived Xenografts with Autologous Human Immune Systems
$750,000Richard D Schulick · University Of Colorado Denver · P30 · FY2024 · CA
Health Promotion and Disease Prevention Research Centers
$749,999Geri A. Dino · West Virginia University · U48 · FY2023 · DP
Enhanced Metabolomics/Lipidomics with a SCIEX ZenoTOF 7600
$749,999Stephen Barnes · University Of Alabama At Birmingham · S10 · FY2024 · OD
Complex 3-Dimensional in vitro Human Skin Tissue Models for Scleroderma
$749,999Yolanda Camille Nesbeth · Celdara Medical, Llc · R44 · FY2018 · AR
The Translational Development of a Therapeutic For Triple Negative Breast Cancer
$749,960Steven Isaacman · Nanometics, Llc · R44 · FY2016 · CA
Companion Diagnostic for Prediction of Response to Targeted Therapies in Kidney Cancer
$749,959Alexendrine Derrien-Colemyn · 20/20 Genesystems, Inc. · N44 · FY2014 · CA
The Translational Development of a Therapeutic For Triple Negative Breast Cancer
$749,959Steven Isaacman · Nanometics, Llc · R44 · FY2015 · CA
Regulatory Validation of Standardized Clinical Laboratory Immunohistochemistry Controls
$749,890Steven A Bogen · Boston Cell Standards Inc · R44 · FY2017 · CA
DICER-Dx: The First Liquid Biopsy for Early Detection and Monitoring of DICER1 Syndrome Pediatric Cancers
$749,883Dana Ashley Hill · Resourcepath, Llc · R44 · FY2019 · CA
Multiphoton intravital microscope
$749,854Margarida Barroso · Albany Medical College · S10 · FY2024 · OD
Pulmonary Hypertension in Genetically Modified Mice
$749,819Marlene Rabinovitch · Stanford University · R01 · FY2021 · HL
Translational Studies of the Histone Deacetylase Inhibitor Romidepsin
$749,814Susan Bates · Division Of Basic Sciences - Nci · ZIA · FY2010 · CA
Characterizing Genetic Susceptibility to Breast and Prostate Cancer; the BPC3
$749,811Brian E Henderson · University Of Southern California · U01 · FY2008 · CA